Keywords: loss, down, rocketing, sales, genmab, copenhagen, denmark-based

Loss down on rocketing sales for Genmab

Article | 15 May 2009

Print This

Copenhagen, Denmark-based biotechnology company Genmab narrowed its first-quarter 2009 loss by 5%, year-on-year, on rocketing sales and R&D cuts.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in